Data as of Sep 15
| -0.17 / -0.91%|
The 7 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 20.00, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +8.11% increase from the last price of 18.50.
The current consensus among 10 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.